Argenx
ARGX
#419
Rank
โ‚น5.056 T
Marketcap
โ‚น81,190
Share price
-1.62%
Change (1 day)
56.94%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2025 (TTM): โ‚น776.72

According to Argenx 's latest financial reports the company's current EPS (TTM) is โ‚น799.13. In 2024 the company made an earnings per share (EPS) of โ‚น1,254 an increase over its 2023 EPS that were of -โ‚น464.89.

EPS history for Argenx from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น776.72-38.07%
2024โ‚น1,254-369.77%
2023-โ‚น464.89-60.46%
2022-โ‚น1,17663.33%
2021-โ‚น719.85-40.37%
2020-โ‚น1,207183.47%
2019-โ‚น425.89123.09%
2018-โ‚น190.9154.93%
2017-โ‚น123.2214.07%
2016-โ‚น108.0213.05%
2015-โ‚น95.54-36.34%
2014-โ‚น150.09209.04%
2013-โ‚น48.57-33.99%
2012-โ‚น73.58185.59%
2011-โ‚น25.76